Polo-like kinase 1 as a potential therapeutic target and prognostic factor for various human malignancies: A systematic review and meta-analysis
ObjectiveThe overexpression of polo-like kinase 1 (PLK-1) has been found in a broad spectrum of human tumors, making it an attractive prognostic tumor biomarker. Nowadays, PLK-1 is considered a cancer therapeutic target with clinical therapeutic value. The aim of the present study was to systematica...
Main Authors: | Ming-Wen Wang, Zhong Li, Li-Hong Chen, Ning Wang, Jian-Ming Hu, Jin Du, Li-Juan Pang, Yan Qi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.917366/full |
Similar Items
-
Role of TSP-1 as prognostic marker in various cancers: a systematic review and meta-analysis
by: Shengjie Sun, et al.
Published: (2020-06-01) -
Identification of polo‐like kinase 1 as a therapeutic target in murine lupus
by: Yaxi Li, et al.
Published: (2022-01-01) -
FancJ regulates interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1
by: Jianqiu Zou, et al.
Published: (2013-08-01) -
Polo-like kinase 1 is related with malignant characteristics and inhibits macrophages infiltration in glioma
by: Lin Luo, et al.
Published: (2022-12-01) -
Genetic Deletion of Polo-Like Kinase 2 Induces a Pro-Fibrotic Pulmonary Phenotype
by: Theresa A. Kant, et al.
Published: (2021-03-01)